Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2012
Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study
M Leahy, X Garcia Del Muro, P Reichardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 1998
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3)
M Gershanovich, H A Chaudri, D Campos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy
P Reichardt, G Von Minckwitz, P C Thuss-Patience, et al.
ESMO Open
|
July 16, 2021
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
M Eriksson, P Reichardt, H Joensuu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2009
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib
M Montemurro, P Schöffski, P Reichardt, et al.
British Journal of Cancer
|
January 18, 2014
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
S Bauer, R A Hilger, T Mühlenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2005
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
M Karthaus, A Kretzschmar, H Kröning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors
A J Wagner, H Kindler, H Gelderblom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2012
Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}
P C Thuss-Patience, R D Hofheinz, D Arnold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 27, 2012
Adjuvant therapy in primary GIST: state-of-the-art
P Reichardt, J-Y Blay, I Boukovinas, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2012
Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study
M Leahy, X Garcia Del Muro, P Reichardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 1998
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3)
M Gershanovich, H A Chaudri, D Campos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy
P Reichardt, G Von Minckwitz, P C Thuss-Patience, et al.
ESMO Open
|
July 16, 2021
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
M Eriksson, P Reichardt, H Joensuu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2009
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib
M Montemurro, P Schöffski, P Reichardt, et al.
British Journal of Cancer
|
January 18, 2014
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
S Bauer, R A Hilger, T Mühlenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2005
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
M Karthaus, A Kretzschmar, H Kröning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors
A J Wagner, H Kindler, H Gelderblom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2012
Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}
P C Thuss-Patience, R D Hofheinz, D Arnold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 27, 2012
Adjuvant therapy in primary GIST: state-of-the-art
P Reichardt, J-Y Blay, I Boukovinas, et al.
Page
of 8